CGEM earnings
Cullinan Therapeutics (CGEM) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.
CGEM earnings history
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q2 2026 | Aug 6, 2026 | -0.81 | -0.80 | -1.34% | – |
| Q1 2026 | May 7, 2026 | -0.75 | -0.84 | 10.27% | – |
| Q4 2025 | Mar 10, 2026 | -0.77 | -0.80 | 3.75% | – |
| Q3 2025 | Nov 6, 2025 | -0.77 | -0.95 | 18.95% | – |
| Q2 2025 | Aug 7, 2025 | -1.07 | -0.83 | -28.92% | – |
| Q1 2025 | May 8, 2025 | -0.74 | -0.78 | 5.13% | – |
| Q4 2024 | Feb 27, 2025 | -0.73 | -0.75 | 2.67% | – |
| Q3 2024 | Nov 7, 2024 | -0.69 | -0.78 | 11.54% | – |
| Q2 2024 | Aug 8, 2024 | -0.75 | -0.73 | -2.74% | – |
| Q1 2024 | May 15, 2024 | -0.86 | -0.90 | 4.44% | – |
| Q4 2023 | Mar 14, 2024 | -0.54 | -0.96 | 43.75% | – |
| Q3 2023 | Nov 8, 2023 | -0.91 | -0.91 | 0.00% | – |
| Q2 2023 | Aug 10, 2023 | -0.82 | -0.99 | 17.17% | – |
| Q1 2023 | May 11, 2023 | -1.42 | -0.84 | -69.05% | – |
| Q4 2022 | Mar 9, 2023 | -0.59 | -0.65 | 9.23% | $0.00 |
| Q3 2022 | Nov 14, 2022 | -0.54 | -0.97 | 44.33% | $0.00 |
- CGEM beat EPS estimates in 12 of its last 16 reports.
Updated 2026-11-10 04:46 UTC